(CLOV) Clover Health Investments - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US18914F1030

CLOV: Medicare, Plans, Software, Insurance, Healthcare, Services, Platform

Clover Health Investments Corp (NASDAQ: CLOV) stands at the intersection of healthcare and technology, offering Medicare Advantage plans with a twist of innovation. Their approach is rooted in data-driven insights, leveraging a cloud-based platform, Clover Assistant, which empowers physicians to predict and manage chronic diseases earlier and more effectively. This tool aggregates data from diverse sources, enabling doctors to make informed decisions, a hallmark of value-based care. Headquartered in Franklin, Tennessee, Clover Health operates in two segments: Insurance and Non-Insurance, distinguishing itself as a tech-driven insurer in a traditional field.

With a market capitalization of $2.16 billion, Clover Health presents an intriguing case for investors. The P/S ratio of 1.02 reflects revenue generation aligned with market value, while a P/B ratio of 6.33 hints at high growth expectations. As a pioneer in value-based care, Clover Health aligns payment with patient outcomes, aiming to reduce costs and enhance quality. This strategic positioning in a rapidly evolving industry underscores their potential as a disruptor, making them a notable entity for those eyeing the healthcare technology landscape.

Additional Sources for CLOV Stock

CLOV Stock Overview

Market Cap in USD 1,768m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Health Care Services
IPO / Inception 2001-01-02

CLOV Stock Ratings

Growth 5y -39.3%
Fundamental -23.6%
Dividend 0.0%
Rel. Strength Industry 400
Analysts 4/5
Fair Price Momentum 3.31 USD
Fair Price DCF 0.50 USD

CLOV Dividends

No Dividends Paid

CLOV Growth Ratios

Growth Correlation 3m 49.9%
Growth Correlation 12m 91.3%
Growth Correlation 5y -67.6%
CAGR 5y -19.37%
CAGR/Max DD 5y -0.20
Sharpe Ratio 12m 0.84
Alpha 384.35
Beta 2.51
Volatility 88.58%
Current Volume 5221.6k
Average Volume 20d 6549.7k
What is the price of CLOV stocks?
As of March 15, 2025, the stock is trading at USD 3.66 with a total of 5,221,611 shares traded.
Over the past week, the price has changed by +0.55%, over one month by -17.94%, over three months by +17.31% and over the past year by +404.83%.
Is Clover Health Investments a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Clover Health Investments is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -23.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOV as of March 2025 is 3.31. This means that CLOV is currently overvalued and has a potential downside of -9.56%.
Is CLOV a buy, sell or hold?
Clover Health Investments has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CLOV.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CLOV stock price target?
According to ValueRays Forecast Model, CLOV Clover Health Investments will be worth about 3.9 in March 2026. The stock is currently trading at 3.66. This means that the stock has a potential upside of +6.28%.
Issuer Forecast Upside
Wallstreet Target Price 4.8 29.8%
Analysts Target Price 4.7 27.9%
ValueRay Target Price 3.9 6.3%